BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ipca Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524494
ISIN Demat
INE571A01038
Book Value (Rs)
271.6399623
NSE Symbol
IPCALAB
Divident Yield %
0.31
Market Cap
(Rs In Cr.)
33,050
P/E (TTM)
36.4
EPS (TTM)
35.79
Face Value
(Rs)
1
Back
Ipca teams with BioSimilar Sciences PR LLC
24-Sep-25   Hrs IST

Ipca Laboratories and BioSimilar Sciences PR LLC (BSS) today announced a definitive Technology Transfer and Joint Development Agreement that will shift late-stage development, clinical manufacture, and commercial supply of a next generation anti-cancer / anti-inflammatory monoclonal antibody biosimilar being developed by Ipca to BioSimilar Sciences PR LLC (BSS) 200,000 square feet sterile campus in Aguadilla, Puerto Rico.

 
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)